Clinical Trial Update: Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 dose-finding study of KRN125 (pegfilgrastim) for neutropenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia

Drugs mentioned

• Pegfilgrastim (KRN125) (pegfilgrastim)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Neutropenia | Phase 2 | Status: COMPLETED